Skip to main content
. 2021 Jul 20;27(20):5576–5585. doi: 10.1158/1078-0432.CCR-21-1083

Figure 4.

Figure 4. Cumulative incidence for relapse for RNA-negative/positive patients, as defined at diagnosis. Gray's test was used to compute the P value.

Cumulative incidence for relapse for RNA-negative/positive patients, as defined at diagnosis. Gray's test was used to compute the P value.